You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allo-HSCT controls

Showing 1 - 25 of 6,330
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Neuronal Networks, Chemosensory and Trigeminal Functions

Recruiting
  • Hematopoietic Stem Cell Transplantation
    • Oslo, Norway
      University of Oslo
    Aug 21, 2023

    Myeloid Leukemia, MDS Trial (IFN-?)

    Not yet recruiting
    • Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Nov 15, 2023

    Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

    Recruiting
    • Hematologic Malignancy
    • Stem Cell Transplant Complications
    • Beijing protocol
    • Beijing, Beijing, China
      Deparment of Hematology, Peking University People's Hospital
    Jun 19, 2023

    Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

    Recruiting
    • Acute Myeloid Leukemia
    • RC1012 injection (allo-DNT cells)
    • Hefei, Anhui, China
      The First Hospital of the University of Science and Technology o
    May 17, 2023

    Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

    Withdrawn
    • Prophylactic HQP1351 Therapy
    • Third Generation TKI
    • HQP1351( Olverembatinib dimesylate)
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Jan 16, 2023

    Immune Reconstitution After Allo-HSCT and Blinatumomab

    Not yet recruiting
    • Leukemia, Lymphoid
    • (no location specified)
    Oct 3, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Acute Lymphoblastic Leukemia
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 27, 2023

    Alterations in Intestinal Microbiota, Metabolites, and Immune

    Recruiting
    • Graft Vs Host Disease
    • Blood Sample
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 16, 2023

    Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • allogenic NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Leukemia Trial (Prehabilitation)

    Not yet recruiting
    • Leukemia
    • Prehabilitation
    • (no location specified)
    Dec 5, 2022

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Not yet recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 3, 2023

    Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +3 more
    • Venetoclax plus RIC
    • Shanghai, Shanghai, China
      Shanghai General Hospital
    Oct 12, 2022

    Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

    Recruiting
    • Myeloid Malignancies
    • fractionated busulfan-based conditioning regimen
    • Chendu, Sichuan, China
      West China Hospital, Sichuan University
    Mar 29, 2023

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 28, 2022

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023

    The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Dec 27, 2022

    Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

    Active, not recruiting
    • Relapsed Adult ALL
    • Relapsed Adult AML
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Nov 19, 2023

    Allo-HSCT as First-line Consolidation in High-risk PTCL

    Recruiting
    • T Cell Lymphoma
      • Beijing, China
        Peking University People's Hospital
      Jul 31, 2022

      Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

      Not yet recruiting
      • Poor Graft Function
      • (no location specified)
      Dec 29, 2022

      Resolving Inflammaging Allo HSCT Survivors in Personal Training

      Completed
      • Allogeneic HCT Survivors
      • 10 Weeks of Strength Trailing
      • Group Nutrition Discussion: week 1, week 5 and week 10
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Mar 31, 2022